Eudaimonia Asset Management »

Protagonist Therapeutics shares owned by Eudaimonia Asset Management

Quarter-by-quarter ownership of Protagonist Therapeutics (PTGX) shares owned by Eudaimonia Asset Management from 13F filings

Historical chart of Eudaimonia Asset Management investment in Protagonist Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Protagonist Therapeutics held by Eudaimonia Asset Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Protagonist Therapeutics by Eudaimonia Asset Management

Quarter filed Position value Share count Share price at filing
2025-09-30 $5.2M 80k 65.36
2025-06-30 $4.0M 72k 55.27
2025-03-31 $3.3M 69k 48.36
2023-06-30 $2.4M 88k 27.62
2021-06-30 $4.5M 101k 44.88
2020-12-31 $888k 44k 20.15
2020-09-30 $1.5M 74k 19.54

More positions owned by Eudaimonia Asset Management

Credo Technology Group Holding Common Stock (CRDO)
Kratos Defense & Security Solutions Common Stock (KTOS)
Sterling Infrastructure Common Stock (STRL)
Primoris Services Corp Common Stock (PRIM)
Rambus Common Stock (RMBS)
IonQ Common Stock (IONQ)
TTM Technologies Common Stock (TTMI)
Advanced Energy Industries Common Stock (AEIS)
Blackrock Funds - Equities ETF (SMIN)
Fabrinet Common Stock (FN)
nLight Common Stock (LASR)
SPX Technologies Common Stock (SPXC)
AeroVironment Common Stock (AVAV)
Bloom Energy Corp Common Stock (BE)
Talen Energy Corp Common Stock (TLN)

View all positions for Eudaimonia Asset Management

Top funds holding Protagonist Therapeutics

BlackRock
Farallon Capital Management
Rtw Investments
Vanguard Group
State Street Corporation
BVF
Johnson & Johnson
Wellington Management Company
UBS Group
Deep Track Capital
Woodline Partners
Geode Capital Management
Driehaus Capital Management
Henderson Group
Marshall Wace

View all funds holding Protagonist Therapeutics